Activin and inhibin

inhibin, alpha
Identifiers
SymbolINHA
NCBI gene3623
HGNC6065
OMIM147380
RefSeqNM_002191
UniProtP05111
Other data
LocusChr. 2 q33-qter
Search for
StructuresSwiss-model
DomainsInterPro
inhibin, beta A
The Activin dimer, from 2ARV.pdb
Identifiers
SymbolINHBA
Alt. symbolsactivin A
NCBI gene3624
HGNC6066
OMIM147290
RefSeqNM_002192
UniProtP08476
Other data
LocusChr. 7 p15-p13
Search for
StructuresSwiss-model
DomainsInterPro
inhibin, beta B
Identifiers
SymbolINHBB
Alt. symbolsactivin B
NCBI gene3625
HGNC6067
OMIM147390
RefSeqNM_002193
UniProtP09529
Other data
LocusChr. 2 cen-q13
Search for
StructuresSwiss-model
DomainsInterPro
inhibin, beta C
Identifiers
SymbolINHBC
Alt. symbolsactivin C
NCBI gene3626
HGNC6068
OMIM601233
RefSeqNM_005538
UniProtP55103
Other data
LocusChr. 12 q13
Search for
StructuresSwiss-model
DomainsInterPro
inhibin, beta E
Identifiers
SymbolINHBE
Alt. symbolsactivin E
NCBI gene83729
HGNC24029
OMIM612031
RefSeqNM_031479
UniProtP58166
Other data
LocusChr. 12 q13.2
Search for
StructuresSwiss-model
DomainsInterPro

Activin and inhibin are two closely related protein complexes that have almost directly opposite biological effects. Identified in 1986,[1][2] activin enhances FSH biosynthesis and secretion, and participates in the regulation of the menstrual cycle. Many other functions have been found to be exerted by activin, including roles in cell proliferation, differentiation, apoptosis,[3] metabolism, homeostasis, immune response, wound repair,[4] and endocrine function. Conversely, inhibin downregulates FSH synthesis and inhibits FSH secretion.[5] The existence of inhibin was hypothesized as early as 1916; however, it was not demonstrated to exist until Neena Schwartz and Cornelia Channing's work in the mid-1970s, after which both proteins were molecularly characterized ten years later.[6]

Activin is a dimer composed of two identical or very similar beta subunits. Inhibin is also a dimer wherein the first component is a beta subunit similar or identical to the beta subunit in activin. However, in contrast to activin, the second component of the inhibin dimer is a more distantly-related alpha subunit.[7][8] Activin, inhibin and a number of other structurally related proteins such as anti-Müllerian hormone, bone morphogenetic protein, and growth differentiation factor belong to the TGF-β protein superfamily.[9]

  1. ^ Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, et al. (1986). "Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid". Nature. 321 (6072): 776–9. Bibcode:1986Natur.321..776V. doi:10.1038/321776a0. PMID 3012369. S2CID 4365045.
  2. ^ Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, et al. (1986). "Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin". Nature. 321 (6072): 779–82. Bibcode:1986Natur.321..779L. doi:10.1038/321779a0. PMID 3086749. S2CID 38100413.
  3. ^ Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Chung J, et al. (May 2006). "Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis". Experimental Biology and Medicine. 231 (5): 534–44. doi:10.1177/153537020623100507. PMID 16636301. S2CID 39050907.
  4. ^ Sulyok S, Wankell M, Alzheimer C, Werner S (October 2004). "Activin: an important regulator of wound repair, fibrosis, and neuroprotection". Molecular and Cellular Endocrinology. 225 (1–2): 127–32. doi:10.1016/j.mce.2004.07.011. PMID 15451577. S2CID 6943949.
  5. ^ van Zonneveld P, Scheffer GJ, Broekmans FJ, Blankenstein MA, de Jong FH, Looman CW, et al. (March 2003). "Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women". Human Reproduction. 18 (3): 495–501. doi:10.1093/humrep/deg138. PMID 12615813.
  6. ^ Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WP, Schwartz NB, et al. (October 2014). "Inhibin at 90: from discovery to clinical application, a historical review". Endocrine Reviews. 35 (5): 747–94. doi:10.1210/er.2014-1003. PMC 4167436. PMID 25051334.
  7. ^ Burger HG, Igarashi M (April 1988). "Inhibin: definition and nomenclature, including related substances". The Journal of Clinical Endocrinology and Metabolism. 66 (4): 885–6. PMID 3346366.
  8. ^ Robertson DM, Burger HG, Fuller PJ (March 2004). "Inhibin/activin and ovarian cancer". Endocrine-Related Cancer. 11 (1): 35–49. doi:10.1677/erc.0.0110035. PMID 15027884. S2CID 12202820.
  9. ^ Cite error: The named reference pmid8299934 was invoked but never defined (see the help page).